# AVS After 1mg DST to Determine Subtype in PA

> **NCT04709185** · NA · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 110 (actual)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **DRUG:** Dexamethasone 1 MG Oral Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04709185
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04709185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04709185, "AVS After 1mg DST to Determine Subtype in PA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04709185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*